How a Hollywood icon and a scientist merged forces to combat the AIDS crisis
In short: In 1985, actress Elizabeth Taylor and researcher Mathilde Krim united their separate foundations to create amfAR. By blending high-profile celebrity advocacy with rigorous scientific funding, they transformed how the world approached HIV, moving from public stigma toward clinical research, policy reform, and a persistent, global search for a cure.
The formation of amfAR in September 1985 represented a unique synthesis of healthcare priorities. Elizabeth Taylor brought the National AIDS Research Foundation, focused on drug development, while Mathilde Krim contributed the AIDS Medical Foundation, which prioritized reducing social stigma. This merger created an organization that functioned as both a research powerhouse and a political lobby. Taylor, serving as the founding national chairman, utilized her celebrity status to secure major donations and force the AIDS epidemic into the national conversation, notably testifying before Congress to advocate for the Comprehensive AIDS Resources Emergency Act of 1990.
The organization's influence expanded through strategic international initiatives. In 2001, amfAR established a headquarters in Bangkok to support TREAT Asia, a network of clinics across East Asia. This move allowed the foundation to leverage local resources and streamline logistics for regional HIV treatment. Simultaneously, the foundation pioneered community-based research, funding early needle exchange programs in cities like Portland and Tacoma. These studies provided critical data demonstrating that such interventions could effectively lower HIV transmission rates among vulnerable populations, despite the intense political opposition during the era's war on drugs.
Today, amfAR continues to drive scientific innovation through the Mathilde Krim Fellowship and the Countdown to a Cure for AIDS initiative. Launched in 2014, the latter aims to secure a functional cure by investing heavily in research consortia like ARCHE. While the foundation has faced internal controversies—including investigations into financial dealings involving former leadership—it remains a significant force in global health. With over $900 million invested in research and more than 3,800 grants awarded, amfAR maintains a focus on bridging the gap between basic biomedical discovery and the practical, life-saving treatments required by patients worldwide.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: AmfAR
To cite this card, link to https://intellectplus.co.uk/app/music-amfar.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Music · More in Music · Latest · A–Z · All topics
